TIRZEPATIDE and VOMITING

5,685 reports of this reaction

2.9% of all TIRZEPATIDE reports

#7 most reported adverse reaction

Overview

VOMITING is the #7 most commonly reported adverse reaction for TIRZEPATIDE, manufactured by Eli Lilly and Company. There are 5,685 FDA adverse event reports linking TIRZEPATIDE to VOMITING. This represents approximately 2.9% of all 196,029 adverse event reports for this drug.

TIRZEPATIDE has an overall safety score of 78 out of 100. Patients taking TIRZEPATIDE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

VOMITING5,685 of 196,029 reports

VOMITING is a less commonly reported adverse event for TIRZEPATIDE, but still significant enough to appear in the safety profile.

Other Side Effects of TIRZEPATIDE

In addition to vomiting, the following adverse reactions have been reported for TIRZEPATIDE:

INCORRECT DOSE ADMINISTERED — 25,919 reports
INJECTION SITE PAIN — 12,325 reports
NAUSEA — 12,028 reports
EXTRA DOSE ADMINISTERED — 8,027 reports
OFF LABEL USE — 7,726 reports
DIARRHOEA — 6,720 reports
INJECTION SITE HAEMORRHAGE — 4,746 reports
ACCIDENTAL UNDERDOSE — 4,444 reports
INJECTION SITE ERYTHEMA — 4,295 reports
CONSTIPATION — 4,190 reports

Other Drugs Associated with VOMITING

The following drugs have also been linked to vomiting in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABALOPARATIDE ABEMACICLIB ACETAMINOPHEN ACETAMINOPHEN 325 MG ACETAMINOPHEN 325MG ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE PHOSPHATE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL

Frequently Asked Questions

Does TIRZEPATIDE cause VOMITING?

VOMITING has been reported as an adverse event in 5,685 FDA reports for TIRZEPATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is VOMITING with TIRZEPATIDE?

VOMITING accounts for approximately 2.9% of all adverse event reports for TIRZEPATIDE, making it a notable side effect.

What should I do if I experience VOMITING while taking TIRZEPATIDE?

If you experience vomiting while taking TIRZEPATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

TIRZEPATIDE Full Profile All Drugs Causing VOMITING Eli Lilly and Company Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.